# First Community Corp: financial statements, quarterly

FCCO · Nasdaq · CIK 932781 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/fcco.md) · [Financials](/companies/fcco/financials.md) · [Filings](/companies/fcco/filings.md) · [Insiders](/companies/fcco/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/fcco/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $k | [240](/filings/0001552781-24-000591.md) | [271 d](/filings/0001552781-26-000126.md) | [259](/filings/0001552781-25-000171.md) | [235](/filings/0001552781-25-000253.md) | [228](/filings/0001552781-25-000402.md) | [230 d](/filings/0001552781-26-000126.md) | [221](/filings/0001552781-26-000341.md) | [224](/filings/0001552781-26-000438.md) | [243](/filings/0001552781-25-000402.md) | [234 d](/filings/0001552781-26-000126.md) | [223](/filings/0001552781-26-000341.md) | [213](/filings/0001552781-26-000438.md) |
| Interest expense | $k | [6,631](/filings/0001552781-24-000591.md) | [8,281 d](/filings/0001552781-26-000126.md) | [9,179](/filings/0001552781-25-000171.md) | [9,237](/filings/0001552781-25-000253.md) | [9,749](/filings/0001552781-25-000402.md) | [9,217 d](/filings/0001552781-26-000126.md) | [8,692](/filings/0001552781-26-000341.md) | [8,849](/filings/0001552781-26-000438.md) | [8,908](/filings/0001552781-25-000402.md) | [8,583 d](/filings/0001552781-26-000126.md) | [9,670](/filings/0001552781-26-000341.md) | [9,674](/filings/0001552781-26-000438.md) |
| Income tax | $k | [464](/filings/0001552781-24-000591.md) | [850 d](/filings/0001552781-26-000126.md) | [730](/filings/0001552781-25-000171.md) | [774](/filings/0001552781-25-000253.md) | [1,146](/filings/0001552781-25-000402.md) | [1,165 d](/filings/0001552781-26-000126.md) | [1,184](/filings/0001552781-26-000341.md) | [1,498](/filings/0001552781-26-000438.md) | [1,396](/filings/0001552781-25-000402.md) | [1,576 d](/filings/0001552781-26-000126.md) | [437](/filings/0001552781-26-000341.md) | [2,144](/filings/0001552781-26-000438.md) |
| Net income | $k | [1,756](/filings/0001552781-24-000591.md) | [3,297 d](/filings/0001552781-26-000126.md) | [2,597](/filings/0001552781-25-000171.md) | [3,265](/filings/0001552781-25-000253.md) | [3,861](/filings/0001552781-25-000402.md) | [4,232 d](/filings/0001552781-26-000126.md) | [3,997](/filings/0001552781-26-000341.md) | [5,186](/filings/0001552781-26-000438.md) | [5,192](/filings/0001552781-25-000402.md) | [4,830 d](/filings/0001552781-26-000126.md) | [5,498](/filings/0001552781-26-000341.md) | [7,595](/filings/0001552781-26-000438.md) |
| Diluted EPS | $ per share | [0.23](/filings/0001552781-24-000591.md) | not reported | [0.34](/filings/0001552781-25-000171.md) | [0.42](/filings/0001552781-25-000253.md) | [0.50](/filings/0001552781-25-000402.md) | not reported | [0.51](/filings/0001552781-26-000341.md) | [0.67](/filings/0001552781-26-000438.md) | [0.67](/filings/0001552781-25-000402.md) | not reported | [0.59](/filings/0001552781-26-000341.md) | [0.80](/filings/0001552781-26-000438.md) |
| Basic EPS | $ per share | [0.23](/filings/0001552781-24-000591.md) | not reported | [0.34](/filings/0001552781-25-000171.md) | [0.43](/filings/0001552781-25-000253.md) | [0.51](/filings/0001552781-25-000402.md) | not reported | [0.52](/filings/0001552781-26-000341.md) | [0.68](/filings/0001552781-26-000438.md) | [0.68](/filings/0001552781-25-000402.md) | not reported | [0.60](/filings/0001552781-26-000341.md) | [0.81](/filings/0001552781-26-000438.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Total assets | $m | [1,794](/filings/0001552781-23-000442.md) | [1,828](/filings/0001552781-25-000082.md) | [1,887](/filings/0001552781-24-000315.md) | [1,885](/filings/0001552781-24-000471.md) | [1,944](/filings/0001552781-24-000591.md) | [1,958](/filings/0001552781-26-000126.md) | [2,039](/filings/0001552781-25-000171.md) | [2,046](/filings/0001552781-25-000253.md) | [2,067](/filings/0001552781-25-000402.md) | [2,058](/filings/0001552781-26-000438.md) | [2,392](/filings/0001552781-26-000341.md) | [2,372](/filings/0001552781-26-000438.md) |
| Total liabilities | $m | [1,670](/filings/0001552781-23-000442.md) | [1,697](/filings/0001552781-25-000082.md) | [1,753](/filings/0001552781-24-000315.md) | [1,749](/filings/0001552781-24-000471.md) | [1,800](/filings/0001552781-24-000591.md) | [1,814](/filings/0001552781-26-000126.md) | [1,889](/filings/0001552781-25-000171.md) | [1,891](/filings/0001552781-25-000253.md) | [1,905](/filings/0001552781-25-000402.md) | [1,890](/filings/0001552781-26-000438.md) | [2,171](/filings/0001552781-26-000341.md) | [2,144](/filings/0001552781-26-000438.md) |
| Shareholders' equity | $m | [124](/filings/0001552781-24-000591.md) | [131](/filings/0001552781-26-000126.md) | [133](/filings/0001552781-25-000253.md) | [136](/filings/0001552781-25-000402.md) | [143](/filings/0001552781-25-000402.md) | [144](/filings/0001552781-26-000438.md) | [150](/filings/0001552781-26-000438.md) | [156](/filings/0001552781-26-000438.md) | [162](/filings/0001552781-25-000402.md) | [168](/filings/0001552781-26-000438.md) | [221](/filings/0001552781-26-000438.md) | [228](/filings/0001552781-26-000438.md) |

- Cash and equivalents: not reported
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [3.0 d](/filings/0001552781-24-000591.md) | [9.3 d](/filings/0001552781-26-000126.md) | [4.7](/filings/0001552781-25-000171.md) | [(0.3) d](/filings/0001552781-25-000253.md) | [10.8 d](/filings/0001552781-25-000402.md) | [(3.6) d](/filings/0001552781-26-000126.md) | [6.5](/filings/0001552781-26-000341.md) | [0.1 d](/filings/0001552781-26-000438.md) | [8.8 d](/filings/0001552781-25-000402.md) | [3.3 d](/filings/0001552781-26-000126.md) | [(2.4)](/filings/0001552781-26-000341.md) | [(2.2) d](/filings/0001552781-26-000438.md) |
| Capital expenditure | $m | [0.3 d](/filings/0001552781-24-000591.md) | [0.1 d](/filings/0001552781-26-000126.md) | [0.3](/filings/0001552781-25-000171.md) | [0.3 d](/filings/0001552781-25-000253.md) | [0.2 d](/filings/0001552781-25-000402.md) | [0.3 d](/filings/0001552781-26-000126.md) | [0.2](/filings/0001552781-26-000341.md) | [0.2 d](/filings/0001552781-26-000438.md) | [0.1 d](/filings/0001552781-25-000402.md) | [0.6 d](/filings/0001552781-26-000126.md) | [0.1](/filings/0001552781-26-000341.md) | [0.2 d](/filings/0001552781-26-000438.md) |
| Dividends paid | $m | [1.1 d](/filings/0001552781-24-000591.md) | [1.1 d](/filings/0001552781-26-000126.md) | [1.1](/filings/0001552781-25-000171.md) | [1.1 d](/filings/0001552781-25-000253.md) | [1.1 d](/filings/0001552781-25-000402.md) | [1.1 d](/filings/0001552781-26-000126.md) | [1.1](/filings/0001552781-26-000341.md) | [1.1 d](/filings/0001552781-26-000438.md) | [1.2 d](/filings/0001552781-25-000402.md) | [1.2 d](/filings/0001552781-26-000126.md) | [1.5](/filings/0001552781-26-000341.md) | [1.5 d](/filings/0001552781-26-000438.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: not reported

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | thousands of shares | [7,608](/filings/0001552781-23-000442.md) | [7,644](/filings/0001552781-24-000315.md) | [7,655](/filings/0001552781-24-000471.md) | [7,655](/filings/0001552781-24-000591.md) | [7,680](/filings/0001552781-25-000171.md) | [7,695](/filings/0001552781-25-000253.md) | [7.7](/filings/0001552781-25-000402.md) | [7,768](/filings/0001552781-26-000341.md) | [7,787](/filings/0001552781-26-000438.md) | [7.8](/filings/0001552781-25-000402.md) | [9,345](/filings/0001552781-26-000341.md) | [9,504](/filings/0001552781-26-000438.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 9,399,731 at 2026-08-12, from the cover of the [10-Q filed 2026-08-12](/filings/0001552781-26-000438.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:29 ET. No prices; not investment advice.